Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
Pharmacogenetic (PGx) testing is a promising approach for optimizing drug therapies. However, there is limited knowledge regarding its real-world utilization and long-term impact in clinical practice. This study assessed how often PGx information informs treatment decisions and evaluated patients’ p...
Saved in:
| Main Authors: | Anna Bollinger, Melissa Semedo Fortes, Henriette E. Meyer zu Schwabedissen, Kurt E. Hersberger, Céline K. Stäuble, Samuel S. Allemann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/13/1/14 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management
by: Anna Bollinger, et al.
Published: (2025-07-01) -
Clinicians’ experience on the effectiveness of pharmacotherapy in patients with first-episode depression: a randomized controlled trial based on pharmacogenomics
by: Jie Tong, et al.
Published: (2025-08-01) -
Correction: Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-07-01) -
Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-05-01) -
Perspektif Hukum Tentang Penerapan Layanan Hak Tanggungan Elektronik
by: Sri Rumada Sihite, et al.
Published: (2023-04-01)